gemcitabine
chemical compound
Facts
19 properties- Instance of
- type of chemical entity
- Part of
- response to gemcitabine[8]
- Has use
- medication[9]
- Active ingredient in
- Gemzar
- Canonical SMILES
- C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F[5]
- Catalog
- CAS COVID-19 Anti-Viral Candidate Compounds
- Chemical formula
- C₉H₁₁F₂N₃O₄[6]
- Found in taxon
- Aspergillus violaceofuscus, Penicillium brocae
- Has active ingredient
- Gemcitabine, Gemcitabine Hydrochloride
- Isomeric SMILES
- C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F
- LiverTox likelihood score
- LiverTox toxicity likelihood category C
- Mass
- 263.072 Da
- Medical condition treated
- cribriform carcinoma, pancreatic ductal carcinoma, transitional cell carcinoma, carcinoma of gallbladder and extrahepatic biliary tract, germ cell cancer, tongue squamous cell carcinoma, head and neck squamous cell carcinoma, bladder cancer, mature T-cell and NK-cell lymphoma, bile duct carcinoma, pancreatic adenocarcinoma, uterus leiomyosarcoma
+10 more
non-small-cell lung carcinoma, invasive ductal carcinoma, squamous cell carcinoma of the lung, non-Hodgkin lymphoma, mycosis fungoides, bone sarcoma, lymphoma, bladder urothelial carcinoma, diffuse large B-cell lymphoma, low-grade serous carcinoma - Physically interacts with
- Ribonucleotide reductase catalytic subunit M1, Ribonucleotide reductase regulatory subunit M2[2][3]
- Pregnancy category
- Australian pregnancy category D, US pregnancy category D
- Subject has role
- DNA polymerase inhibitors, antiviral agent, enzyme inhibitor, antineoplastic antimetabolite, immunosuppressive drug, radiosensitizer, WHO essential medicines, bactericide, antiviral drug
🏷️ Also known as
en gemcitabine
en gemcitabine hydrochloride
en Gemcitabine
en Gemzar®
en Gemcitabinum
en 2',2'-Difluorodeoxycytidine
en 2'-Deoxy-2',2'-difluorocytidine
en 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
en 4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
en Gemcitabin
en Gemcitabina
ar جيمسيتابين
de Gemcitabine
de Gemzar
el Γεµσιταβίνη
el Gemzar
fa جمسیتابین
fi gemsitabiini
fi Gemzar
fr C9H11F2N3O4
🔖 Identifiers · 44
- OpenAlex ID
- C2780258809
- ATC code
- L01BC05
- CAS Registry Number
- 95058-81-4
- ChEBI ID
- 175901
- ChEMBL ID
- CHEMBL888
- ChemSpider ID
- 54753
- DSSTOX compound identifier
- DTXCID1020487
- DSSTox substance ID
- DTXSID3040487
- DrugBank ID
- DB00441
- DrugCentral ID
- 1283
- EC number
- 619-100-6
- ECHA Substance Infocard ID
- 100.124.343
Show all 44 identifiers +32
- Electronic Essential Medicines List medicine ID
- 92
- Encyclopædia Britannica Online ID
- topic/Gemzar
- Freebase ID
- /m/05g9s6
- Guide to Pharmacology Ligand ID
- 4793
- HSDB ID
- 7567
- Human Metabolome Database ID
- HMDB0014584
- InChIKey
- SDUQYLNIPVEERB-QPPQHZFASA-N
- KEGG ID
- C07650
- KNApSAcK ID
- C00063489
- LiverTox ID
- Gemcitabine
- MassBank accession ID
- MSBNK-Athens_Univ-AU210601, MSBNK-Athens_Univ-AU210602, MSBNK-Eawag-EA260301, MSBNK-Eawag-EA260302, MSBNK-Eawag-EA260303, MSBNK-Eawag-EA260304, MSBNK-Eawag-EA260305, MSBNK-Eawag-EA260306, MSBNK-Eawag-EA260307, MSBNK-Eawag-EA260308, MSBNK-Eawag-EA260309, MSBNK-Eawag-EA260310
+18 more
MSBNK-Eawag-EA260311, MSBNK-Eawag-EA260312, MSBNK-Eawag-EA260313, MSBNK-Eawag-EA260314, MSBNK-Eawag-EA260351, MSBNK-Eawag-EA260352, MSBNK-Eawag-EA260353, MSBNK-Eawag-EA260354, MSBNK-Eawag-EA260355, MSBNK-Eawag-EA260356, MSBNK-Eawag-EA260357, MSBNK-Eawag-EA260358, MSBNK-Eawag-EA260359, MSBNK-Eawag-EA260360, MSBNK-Eawag-EA260361, MSBNK-Eawag-EA260362, MSBNK-Eawag-EA260363, MSBNK-Eawag-EA260364 - MeSH descriptor ID
- D000093542
- MeSH tree code
- D03.258, D03.383.742.680.245.500.775
- MedlinePlus drug identifier
- a696019
- Microsoft Academic ID (discontinued)
- 2780258809
- NDF-RT ID
- N0000022036
- National Drug Code
- 43265-7749, 0143-9340, 63323-102, 67457-616, 0409-0183, 63323-125, 72485-223, 0143-9341, 0143-9342, 63323-126, 68001-342, 68001-359
- PDB ligand ID
- GEO
- Probes And Drugs ID
- PD003524
- PubChem CID
- 60750
- Reaxys registry number
- 5382060
- RxNorm CUI
- 12574
- SPLASH
- splash10-03dl-0900000000-01d92fca070f980c2668, splash10-03di-0900000000-95712722811cd50ab160, splash10-03di-0190000000-b97d64dba479bbac0253, splash10-03di-0930000000-fce77aa139fbedd4910b, splash10-03di-0900000000-179a77c420afc3af2544, splash10-03di-1900000000-5569d5d510ca5c1a84ef, splash10-03di-2900000000-eb92e15ff6bb6fafe1dd, splash10-03di-5900000000-7cec5b636c875dcbfced, splash10-03di-0190000000-8d1e58453b0a991c8106, splash10-03di-0930000000-4739133fc80b45fc52ba, splash10-03di-0900000000-8fc0422b65b946f62385, splash10-03di-1900000000-da3f8b2e4b3babb2a4f0
+17 more
splash10-03di-2900000000-ea359abde4b5c6deb936, splash10-03di-5900000000-f8e5e85ba0cd765dff4c, splash10-03di-0900000000-18896272b82c17bec731, splash10-03di-0930000000-e2122f1423d3060097b9, splash10-03di-0790000000-e66897c78fa010a45ab8, splash10-0cfs-0910000000-e4e73c07b687772a1108, splash10-0a4i-0900000000-99f619802e3ba7bd8b2e, splash10-0a4i-0900000000-18dd55d7372a11b9dfb7, splash10-0a4i-1900000000-fdc016f6d17808e4cf1b, splash10-0a4i-5900000000-ec478d4dfe03f80b91ad, splash10-03di-0790000000-0d953fc9632751f00f72, splash10-07xs-0920000000-0e8154089a57b6bef7c4, splash10-0a4i-0900000000-c54a530153a028d6ffcc, splash10-0a4i-0900000000-1f4cd6bc7d377fe7731e, splash10-0a4i-0900000000-c3cdcfa5d386ac7222fa, splash10-0aor-4900000000-337f45a27b7b12b1b2f0, splash10-03di-0920000000-52d24e07b71b7d08dcdb - Store medisinske leksikon ID
- gemcitabin
- SureChEMBL ID
- 4295
- UK Parliament thesaurus ID
- 10425
- UMLS CUI
- C0045093
- UNII
- B76N6SBZ8R
- UniChem compound ID
- 590155
- WikiProjectMed ID
- Gemcitabine
🔗 Connections
Medical condition treated 9
← Drug or therapy used for treatment 9
Subject has role 7
Found in taxon 2
Has use 1
Manufacturer 1
Press Enter · cited answer in seconds
0 sources
Summary
gemcitabine is a type of chemical entity[1].